201 related articles for article (PubMed ID: 35663751)
41. Identification of an Individualized Immune-Related Prognostic Risk Score in Lung Squamous Cell Cancer.
Zhuang Y; Li S; Liu C; Li G
Front Oncol; 2021; 11():546455. PubMed ID: 33747902
[No Abstract] [Full Text] [Related]
42.
Zhang W; Zhang Q; Xie Z; Che L; Xia T; Cai X; Liu S
Front Genet; 2022; 13():839957. PubMed ID: 35719401
[TBL] [Abstract][Full Text] [Related]
43. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
Front Oncol; 2022; 12():876660. PubMed ID: 35747790
[TBL] [Abstract][Full Text] [Related]
44. Ferroptosis-related lncRNAs signature to predict the survival and immune evasion for lung squamous cell carcinoma.
Zhang R; Zhang X; Yang H; Lin Y; Wen Y; Zhao D; Chen L; Lin P; Zhang L
Front Genet; 2022; 13():968601. PubMed ID: 36092894
[No Abstract] [Full Text] [Related]
45. Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma.
Tang RX; Chen WJ; He RQ; Zeng JH; Liang L; Li SK; Ma J; Luo DZ; Chen G
Oncotarget; 2017 Aug; 8(31):50761-50773. PubMed ID: 28881601
[TBL] [Abstract][Full Text] [Related]
46. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY
J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367
[TBL] [Abstract][Full Text] [Related]
47. Construction of a Two-Gene Immunogenomic-Related Prognostic Signature in Lung Squamous Cell Carcinoma.
Zhang X; Xiao J; Fu X; Qin G; Yu M; Chen G; Li X
Front Mol Biosci; 2022; 9():867494. PubMed ID: 35463955
[TBL] [Abstract][Full Text] [Related]
48. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
49. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
[No Abstract] [Full Text] [Related]
50. Exploration of the Immune-Related Long Noncoding RNA Prognostic Signature and Inflammatory Microenvironment for Cervical Cancer.
Yao H; Jiang X; Fu H; Yang Y; Jin Q; Zhang W; Cao W; Gao W; Wang S; Zhu Y; Ying J; Tian L; Chen G; Tong Z; Qi J; Zhou S
Front Pharmacol; 2022; 13():870221. PubMed ID: 35662687
[No Abstract] [Full Text] [Related]
51. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
Bai Y; Lin H; Chen J; Wu Y; Yu S
Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
[No Abstract] [Full Text] [Related]
52. Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma.
Luo P; Jiang Y; Ding S; Jiang S; Tang R; Tang Z
Biomed Res Int; 2022; 2022():4944758. PubMed ID: 35692583
[TBL] [Abstract][Full Text] [Related]
53. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
54. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
55. A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients.
Chen D; Wang M; Xu Y; Jiang X; Xiong L; Zhang L; Yu H; Xiong Z
Int J Gen Med; 2021; 14():6935-6950. PubMed ID: 34703297
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the Prognostic Value of Long Noncoding RNAs in Lung Squamous Cell Carcinoma.
Zhang X; Su Y; Fu X; Xiao J; Qin G; Yu M; Li X; Chen G
J Oncol; 2022; 2022():9273628. PubMed ID: 35069738
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive Analysis of Immune Implication and Prognostic Value of
Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
Front Oncol; 2021; 11():798425. PubMed ID: 35047409
[TBL] [Abstract][Full Text] [Related]
58. N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.
Zhang Y; Zhu B; He M; Cai Y; Ying X; Jiang C; Ji W; Zeng J
Front Oncol; 2021; 11():710767. PubMed ID: 34458149
[TBL] [Abstract][Full Text] [Related]
59. Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma.
Jiang A; Liu N; Bai S; Wang J; Gao H; Zheng X; Fu X; Ren M; Zhang X; Tian T; Ruan Z; Liang X; Yao Y
J Thorac Dis; 2021 Feb; 13(2):720-734. PubMed ID: 33717544
[TBL] [Abstract][Full Text] [Related]
60. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
